Skip to main content

Drugs IPOs Depend on Deals

Biotech IPOs that have relationships with established drug companies will do better than those going it alone.

Disclosure: TheStreet's editorial policy prohibits staff editors, reporters and analysts from holding positions in any individual stocks.